Japan Tob (OTCMKTS:JAPAY) Hits New 1-Year High - Here's Why

Key Points

• Japan Tobacco shares reached a new 52-week high, trading as high as $24.26 before last changing hands at $23.98.
• Analyst sentiment is mixed: BTIG Research initiated coverage with a “Buy” rating, while the overall consensus remains “Hold” with a $17.00 price target.
• The company exceeded quarterly expectations, reporting $0.41 EPS versus the $0.33 estimate and revenue of $6.67 billion compared with the $6.15 billion consensus.

Japan Tob (OTCMKTS:JAPAY - Get Free Report) reached a new 52-week high during mid-day trading on Saturday. The stock traded as high as $24.26 and last traded at $23.98, with a volume of 502,031 shares. The stock had previously closed at $24.00.

Wall Street Analysts Forecast Growth

Separately, BTIG Research started coverage on shares of Japan Tob in a report on Wednesday, July 22nd. They issued a "buy" rating on the stock. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $17.00.

Japan Tob Stock Down 0.1%

The firm has a 50 day moving average price of $22.18 and a 200-day moving average price of $20.37. The firm has a market cap of $85.15 billion, a price-to-earnings ratio of 17.50, a price-to-earnings-growth ratio of 1.59 and a beta of 0.28. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.04 and a quick ratio of 1.45.

Japan Tob (OTCMKTS:JAPAY - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.08. The business had revenue of $6.67 billion during the quarter, compared to the consensus estimate of $6.15 billion. As a group, equities analysts predict that Japan Tob will post 1.13 EPS for the current fiscal year.

About Japan Tob

Japan Tobacco Inc is a Japan-based company engaged primarily in the manufacture and sale of tobacco products. Its portfolio includes cigarettes, heated tobacco products and other reduced-risk products, marketed under brands such as Winston, Camel, Mevius and LD in various markets.

The company also operates businesses in pharmaceutical products and processed foods. Its pharmaceutical operations focus on prescription medicines, while its food business provides products including frozen foods, seasonings and other processed food items.

Japan Tobacco traces its history to Japan's former tobacco monopoly and was established in its current corporate form in 1985.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.